These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 23196330)
1. Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma. Triozzi PL; Elson P; Aldrich W; Achberger S; Tubbs R; Biscotti CV; Singh AD Melanoma Res; 2013 Feb; 23(1):1-7. PubMed ID: 23196330 [TBL] [Abstract][Full Text] [Related]
2. Cytogenetics of uveal melanoma: a 7-year clinical experience. Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643 [TBL] [Abstract][Full Text] [Related]
3. Regression of uveal melanoma after plaque radiotherapy and thermotherapy based on chromosome 3 status. Shields CL; Bianciotto C; Rudich D; Materin MA; Ganguly A; Shields JA Retina; 2008 Oct; 28(9):1289-95. PubMed ID: 18628721 [TBL] [Abstract][Full Text] [Related]
4. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma. Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992 [TBL] [Abstract][Full Text] [Related]
5. The prognostic value of extraocular extension in relation to monosomy 3 and gain of chromosome 8q in uveal melanoma. van Beek JG; Koopmans AE; Vaarwater J; de Rooi JJ; Paridaens D; Naus NC; de Klein A; Verdijk RM; Kiliç E Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1284-91. PubMed ID: 24508790 [TBL] [Abstract][Full Text] [Related]
6. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis. van den Bosch T; van Beek JG; Vaarwater J; Verdijk RM; Naus NC; Paridaens D; de Klein A; Kiliç E Invest Ophthalmol Vis Sci; 2012 May; 53(6):2668-74. PubMed ID: 22427574 [TBL] [Abstract][Full Text] [Related]
7. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss. Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972 [TBL] [Abstract][Full Text] [Related]
8. Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases: the Deborah Iverson, MD, Lectureship. Shields CL; Ganguly A; Materin MA; Teixeira L; Mashayekhi A; Swanson LA; Marr BP; Shields JA Arch Ophthalmol; 2007 Aug; 125(8):1017-24. PubMed ID: 17698747 [TBL] [Abstract][Full Text] [Related]
9. Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma. Bronkhorst IH; Maat W; Jordanova ES; Kroes WG; Schalij-Delfos NE; Luyten GP; Jager MJ Arch Pathol Lab Med; 2011 Aug; 135(8):1042-7. PubMed ID: 21809997 [TBL] [Abstract][Full Text] [Related]
10. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type. Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742 [TBL] [Abstract][Full Text] [Related]
11. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression. Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target. All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005 [TBL] [Abstract][Full Text] [Related]
13. Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens. Shields CL; Ganguly A; Bianciotto CG; Turaka K; Tavallali A; Shields JA Ophthalmology; 2011 Feb; 118(2):396-401. PubMed ID: 20869116 [TBL] [Abstract][Full Text] [Related]
14. Chromosome 3 is a valid marker for prognostic testing of biopsy material from uveal melanoma later treated by brachytherapy. Le Guin CHD; Metz KA; Lehmann N; Kreis SH; Bornfeld N; Rudolf Lohmann D; Zeschnigk M Biomarkers; 2019 Mar; 24(2):134-140. PubMed ID: 30265160 [TBL] [Abstract][Full Text] [Related]
15. Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma. Topcu-Yilmaz P; Kiratli H; Saglam A; Söylemezoglu F; Hascelik G Melanoma Res; 2010 Apr; 20(2):126-32. PubMed ID: 20061986 [TBL] [Abstract][Full Text] [Related]
16. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization. Naus NC; Verhoeven AC; van Drunen E; Slater R; Mooy CM; Paridaens DA; Luyten GP; de Klein A Clin Cancer Res; 2002 Feb; 8(2):534-9. PubMed ID: 11839674 [TBL] [Abstract][Full Text] [Related]
17. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis. Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937 [TBL] [Abstract][Full Text] [Related]